Rankings
▼
Calendar
APLS Q4 2016 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
APLS
Apellis Pharmaceuticals, Inc.
$2B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-0.37
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$316,559
Balance Sheet
Total Assets
$27M
Total Liabilities
$4M
Stockholders' Equity
$24M
Cash & Equivalents
$25M
← FY 2016
All Quarters
Q1 2017 →
